Focus on antivirally active sulfated polysaccharides: From structure–activity analysis to clinical evaluation
The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
In recent years, many compounds having potent antiviral activity in cell culture have been detected and some of these compounds are currently undergoing either preclinical or clinical evaluation. Among these antiviral substances, naturally occurring sulfated polysaccharides and those from synthetic origin are noteworthy. Recently, several controversies over the molecular structures of sulfated polysaccharides, viral glycoproteins, and cell-surface receptors have been resolved, and many aspects of their antiviral activity have been elucidated. It has become clear that the antiviral properties of sulfated polysaccharides are not only a simple function of their charge density and chain length but also their detailed structural features. The in vivo efficacy of these compounds mostly corresponds to their ability to inhibit the attachment of the virion to the host cell surface although in some cases virucidal activity plays an additional role. This review summarizes experimental evidence indicating that sulfated polysaccharides might become increasingly important in drug development for the prevention of sexually transmitted diseases in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,149
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,100
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Cumashi, A., Ushakova, N. A., Preobrazhenskaya, M. E., D'Incecco, A., Piccoli, A., Totani, L., Tinari, N., Morozevich, G. E., Berman, A. E., Bilan, M. I., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm014 · Cited by 1,026
Molecular diversity of heparan sulfate
Esko, J. D., & Lindahl, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13530 · Cited by 951
Antiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
WuDunn, D., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.52-58.1989 · Cited by 919
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Spear, P. G. (1998) · Science · doi:10.1126/science.280.5369.1618 · Cited by 909
Berteau, O. (2003) · Glycobiology · doi:10.1093/glycob/cwg058 · Cited by 769 · cited 1×
“Extensive investigation on polysaccharides from various natural sources showed the presence of several classes of highly interesting macromolecules (Painter 1983; Berteau and Mulloy 2003).”
BackgroundStructure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Cited by
Bioactive compounds in seaweed: functional food applications and legislation
Holdt, S. L., & Kraan, S. (2011) · Journal of Applied Phycology · doi:10.1007/s10811-010-9632-5 · Cited by 2,135
Yu, Y., Shen, M., Song, Q., & Xie, J. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.12.009 · Cited by 1,416
Chemical structures and bioactivities of sulfated polysaccharides from marine algae
Jiao, G., Yu, G., Zhang, J., & Ewart, H. S. (2011) · Marine Drugs · doi:10.3390/md9020196 · Cited by 1,054
Overview of microalgal extracellular polymeric substances (EPS) and their applications
Xiao, R., & Zheng, Y. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.004 · Cited by 938
Advances in bacterial exopolysaccharides: from production to Biotechnological applications
Freitas, F., Alves, V. D., & Reis, M. A. M. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.008 · Cited by 804
Marine Polysaccharides from Algae with Potential Biomedical Applications
De Jesus Raposo, M., De Morais, A., & De Morais, R. (2015) · Marine Drugs · doi:10.3390/md13052967 · Cited by 686
Ulvan: A systematic review of extraction, composition and function
Kidgell, J. T., Magnusson, M., de Nys, R., & Glasson, C. R. K. (2019) · Algal Research · doi:10.1016/j.algal.2019.101422 · Cited by 666
Pereira, S., Zille, A., Micheletti, E., Moradas-Ferreira, P., De Philippis, R., & Tamagnini, P. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00183.x · Cited by 657
Sosnik, A., das Neves, J., & Sarmento, B. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.07.010 · Cited by 487
Exopolysaccharides of lactic acid bacteria: Structure, bioactivity and associations: A review
Zhou, Y., Cui, Y., & Qu, X. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.11.093 · Cited by 412
Synthesis and characterization of Fe3O4 nanoparticles coated with fucan polysaccharides
Silva, V. A. J., Andrade, P. L., Silva, M. P. C., Bustamante D., A., De Los Santos Valladares, L., & Albino Aguiar, J. (2013) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2013.04.062 · Cited by 401
The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview
Wang, W., Wang, S.-X., & Guan, H.-S. (2012) · Marine Drugs · doi:10.3390/md10122795 · Cited by 381
Sulfated polysaccharides as bioactive agents from marine algae
Ngo, D.-H., & Kim, S.-K. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.08.036 · Cited by 287
Algal Polysaccharides, Novel Applications and Outlook
Kraan, S. (2012) · Carbohydrates - Comprehensive Studies on Glycobiology and Glycotechnology · doi:10.5772/51572 · Cited by 270
Ruocco, N., Costantini, S., Guariniello, S., & Costantini, M. (2016) · Molecules · doi:10.3390/molecules21050551 · Cited by 267
Prasanna, P. H. P., Grandison, A. S., & Charalampopoulos, D. (2014) · Food Research International · doi:10.1016/j.foodres.2013.11.013 · Cited by 135
In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii
Dinesh, S., Menon, T., Hanna, L. E., Suresh, V., Sathuvan, M., & Manikannan, M. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.09.078 · Cited by 110
Antioxidant marine products in cancer chemoprevention
Park, E.-J., & Pezzuto, J. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5235 · Cited by 49
“None-theless, the oral availability can be improved by structural modifications, such as curdlan sulfate, highly sulfated mannose-containing oligosaccharides (PI-88), and alginate-derived sulfated oligosaccharides (37).”
InfluentialDietary algae and HIV/AIDS: proof of concept clinical data
Teas, J., & Irhimeh, M. R. (2012) · Journal of Applied Phycology · doi:10.1007/s10811-011-9766-0 · Cited by 43
“…proposed for algal inhibition of HIV including inhibition of viral entry/fusion, reverse transcriptase activity, and integrase and protease activities (Ahn et al. 2004; Baba et al. 1990; Ghosh et al. 2009; McReynolds and Gervay-Hague 2007; Schaeffer and Krylov 2000; Witvrouw and De Clercq 1997).”
BackgroundJinno-Oue, A., Tanaka, A., Shimizu, N., Mori, T., Sugiura, N., Kimata, K., Isomura, H., & Hoshino, H. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0156 · Cited by 21
Metadata
- Authors
- Ghosh, T., Chattopadhyay, K., Marschall, M., Karmakar, P., Mandal, P., & Ray, B.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-24
- Volume
- 19
- Issue
- 1
- Pages
- 2-15
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2096213645
- Cited by
- 391
- References
- 135
- FWCI
- 25.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.